Riskpilot← Back to searchSign inGet full accessOptiwomen Oy
OYActiveY-tunnus 2456809-8Paljekuja 1Retail sale of medical and orthopaedic goods · NACE 4774Est. 2012— employeeswww.specsavers.fi
Revenue 2025
EUR 2M
+8% vs 2024
EBITDA margin
12.9%
+30% vs 2024
Equity ratio
75.6%
Financial strength
Net profit 2025
EUR 148K
+62% vs 2024
| Revenue | EUR 2M | +8% |
| EBITDA | EUR 259K | +30% |
| Net profit | EUR 148K | +62% |
| Total assets | EUR 835K | +7% |
| Equity | EUR 631K | +8% |
| Employees | — | — |
Legal name
Optiwomen Oy
Y-tunnus number
2456809-8
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
25. tammikuuta 2012
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on optisen alan tuotteiden kauppa ja maahantuonti sekä näihin liittyvät palvelut. Yhtiö voi myös omistaa arvopapereita ja kiinteistöjä ja käydä niillä kauppaa.
Address
Paljekuja 1
Email
teija.rimpelainen@st.fi.specsavers.com
Website
www.specsavers.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 647 | 1 688 | 1 836 | 1 852 | 2 003 |
| Staff expenses | −511 | −525 | −586 | −595 | −624 |
| EBITDA | 191 | 201 | 239 | 199 | 259 |
| Depreciation & amort. | −61 | −33 | −47 | −82 | −70 |
| EBIT | 131 | 168 | 192 | 117 | 189 |
| Net financials | −3 | −13 | 2 | −2 | −4 |
| Profit before tax | 129 | 156 | −484 | 115 | 185 |
| Tax | 26 | 32 | 38 | 23 | 37 |
| Net profit | 103 | 123 | −522 | 92 | 148 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 671 | 830 | 910 | 782 | 835 |
| Equity | 510 | 534 | 590 | 582 | 631 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 160 | 297 | 319 | 200 | 204 |
| Total debt | 160 | 297 | 319 | 200 | 204 |
EBITDA margin
12.9%
This company
15.8%
Market median
-18% vs market
20212025
Equity ratio
75.6%
This company
38.2%
Market median
+98% vs market
20212025
Return on equity
23.5%
This company
18.4%
Market median
+28% vs market
20212025
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
20212025
Asset turnover
2.40×
This company
1.12×
Market median
+114% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
TM Chief Executive Officer | Chief Executive Officer | 2012 |
JP Deputy Member | Deputy Member | 2012 |
JR Deputy Member | Deputy Member | 2012 |
SS | Audit | 2025 |
| Former (1) | ||
KP Audit | Audit | 2017 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Optiwomen Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tiina Marianne Huotari | Chief Executive Officer | 0 companies |
| Juho Pekka Karinen | Deputy Member | 0 companies |
| Jyrki Reino Hermanni Huotari | Deputy Member | 0 companies |
| Kari Pekka Knuuttila | Audit | 0 companies |
| Saija Suvi Maaret Väisänen | Audit | 0 companies |
| Teija Eira Elina Rimpeläinen | Chairperson | 0 companies |